Harbin Pharmaceutical Group

Last updated
  1. "HPGC 2022 Semi-Annual Report". Shanghai Stock Exchange. Retrieved November 12, 2022.
  2. "Harbin Pharmaceutical to issue RMB 800 mln short-term bonds". news.alibaba.com. 10 November 2008. Retrieved 2020-09-13.
  3. Ferek, Katy Stech (2020-09-10). "Rubio Seeks Security Review of Chinese Bid for GNC". Wall Street Journal. ISSN   0099-9660 . Retrieved 2020-09-13.
  4. Stevenson, Alexandra; Kulish, Nicholas; Gelles, David (2020-04-24). "Frantic for Coronavirus Gear, Americans in Need Turn to China's Elite". The New York Times. ISSN   0362-4331 . Retrieved 2020-09-13.
  5. "Harbin Pharmaceutical Group Co Ltd - Company Profile and News". Bloomberg.com. Retrieved 2021-03-26.
  6. "GNC Taps 5WPR For Consumer Business". www.provokemedia.com. Retrieved 2021-04-08.
  7. "GNC, China's Harbin Pharmaceutical agree on sale price before auction". New Hope Network. 2020-08-10. Retrieved 2021-04-08.
  8. Yukun, Liu; Hu, Yuanyuan (2018-02-26). "Hayao picks 40% stake in GNC, to also form new JV". China Daily. Retrieved 2022-11-12.
  9. Wang, Qiwen (2022-03-11). "不止茅台,东阿阿胶、哈药等「国家企业技术中心」资格也被撤". The Paper (in Chinese). Archived from the original on 2022-11-12. Retrieved 2022-11-12.
  10. "记录中国|哈药六厂翻红:游客自发挖掘成景,已接待90万人次_深圳新闻网".
Harbin Pharmaceutical Group Co., Ltd.
Company type Public
SSE: 600664
IndustryPharmaceuticals
PredecessorHarbin Pharmaceutical Administration
Founded1988;36 years ago (1988)
Headquarters,
China
Area served
Worldwide
Owner
Number of employees
20,100 (2014)
Subsidiaries
Chinese name
Simplified Chinese 哈药集团有限公司
Traditional Chinese 哈藥集團有限公司
Transcriptions
Standard Mandarin
Hanyu Pinyin Hāyào Jítuán Yǒuxiàn gōngsī